Dublin, March 26, 2025 (GLOBE NEWSWIRE) -- The "Eprinomectin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type" report has been added to ResearchAndMarkets.com's offering.
The global Eprinomectin market is estimated at USD 150 million to USD 180 million in 2025, with a projected CAGR of 5% to 7% from 2025 to 2030, reaching USD 200 million to USD 250 million by 2030, reflecting steady livestock demand.
This market thrives on its critical role in livestock health, driven by global meat demand, animal welfare focus, and regulatory approvals, with trends shifting toward convenient, long-acting formulations like injections and pour-ons.
Regional Analysis
- North America: Growing at 4-6%, the U.S. leads with dairy and beef production, trending toward residue-free solutions.
- Europe: With a 3-5% growth rate, Germany excels in animal health, focusing on sustainable treatments.
- Asia Pacific: Exhibiting a 6-8% growth rate, China dominates with livestock scale, trending toward cost-effective options.
- Middle East and Africa (MEA): Growing at 3-5%, South Africa advances with cattle farming, emphasizing durability.
- South America: With a 5-7% growth rate, Brazil leads with beef exports, focusing on affordability.
Application Analysis
- Cattle: Projected at 5-7%, it dominates with parasite control needs, trending toward long-acting formulations.
- Others: Expected at 4-6%, it serves niche animals, with broader applications rising.
Product Type Analysis
- Eprinomectin Injection: Projected at 5-7%, it excels in precision dosing, trending toward ease of use.
- Eprinomectin Pour-on: Expected at 4-6%, it serves convenience, with durable designs rising.
Key Market Players
- Boehringer Ingelheim: A global leader in veterinary innovations.
- Ceva Sante Animale: A dynamic innovator in animal health solutions.
- Norbrook Laboratories: A reliable provider of effective treatments.
- Virbac: A versatile creator of livestock care products.
- Livisto: A spirited innovator in veterinary solutions.
- Limin Chemical: A resourceful leader in cost-effective options.
- Zhejiang Hisun: A vibrant provider of scalable treatments.
- Eastern Along: A practical innovator in animal care.
- Sichuan Qiquan: A steadfast creator of reliable solutions.
Porter's Five Forces Analysis
- Threat of New Entrants: Medium, with regulatory barriers, though niche firms emerge.
- Threat of Substitutes: Medium, as alternative antiparasitics compete, yet Eprinomectin's efficacy endures.
- Bargaining Power of Buyers: Medium, with farmers negotiating, balanced by specialized needs.
- Bargaining Power of Suppliers: Medium, as chemical reliance grants leverage, offset by scale.
- Competitive Rivalry: High, with quality and pricing driving competition.
Market Opportunities
- Livestock growth: Rising meat demand drives use, enhancing market scope.
- Animal welfare focus: Health priorities boost adoption, targeting efficacy.
- Emerging market potential: Farming growth in Asia Pacific offers avenues, fueled by scale.
- Regulatory approvals: Favorable policies fuel demand, supporting compliance.
- Formulation innovation: Long-acting solutions gain traction, appealing to farmers.
Market Challenges
- High costs: Expensive production limits affordability, challenging scale.
- Substitute rivalry: Alternative drugs threaten share, needing differentiation.
- Regulatory hurdles: Strict standards raise costs, slowing entry.
- Supply chain risks: Raw material shortages disrupt production, testing operations.
- Resistance concerns: Parasite resistance demands innovation, straining resources.
Key Topics Covered
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Eprinomectin Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Eprinomectin by Region
8.2 Import of Eprinomectin by Region
8.3 Balance of Trade
Chapter 9 Historical and Forecast Eprinomectin Market in North America (2020-2030)
9.1 Eprinomectin Market Size
9.2 Eprinomectin Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 United States
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Historical and Forecast Eprinomectin Market in South America (2020-2030)
10.1 Eprinomectin Market Size
10.2 Eprinomectin Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Chile
10.5.4 Peru
Chapter 11 Historical and Forecast Eprinomectin Market in Asia & Pacific (2020-2030)
11.1 Eprinomectin Market Size
11.2 Eprinomectin Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis
11.5.1 China
11.5.2 India
11.5.3 Japan
11.5.4 South Korea
11.5.5 Southeast Asia
11.5.6 Australia
Chapter 12 Historical and Forecast Eprinomectin Market in Europe (2020-2030)
12.1 Eprinomectin Market Size
12.2 Eprinomectin Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis
12.5.1 Germany
12.5.2 France
12.5.3 United Kingdom
12.5.4 Italy
12.5.5 Spain
12.5.6 Belgium
12.5.7 Netherlands
12.5.8 Austria
12.5.9 Poland
12.5.10 Russia
Chapter 13 Historical and Forecast Eprinomectin Market in MEA (2020-2030)
13.1 Eprinomectin Market Size
13.2 Eprinomectin Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis
13.5.1 Egypt
13.5.2 Israel
13.5.3 South Africa
13.5.4 Gulf Cooperation Council Countries
13.5.5 Turkey
Chapter 14 Summary For Global Eprinomectin Market (2020-2025)
14.1 Eprinomectin Market Size
14.2 Eprinomectin Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price
Chapter 15 Global Eprinomectin Market Forecast (2025-2030)
15.1 Eprinomectin Market Size Forecast
15.2 Eprinomectin Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast
Chapter 16 Analysis of Global Key Vendors
16.1 Boehringer Ingelheim
16.1.1 Company Profile
16.1.2 Main Business and Eprinomectin Information
16.1.3 SWOT Analysis of Boehringer Ingelheim
16.1.4 Boehringer Ingelheim Eprinomectin Sales, Revenue, Price and Gross Margin (2020-2025)
16.2 Ceva Sante Animale
16.3 Norbrook Laboratories
16.4 Virbac
16.5 Livisto
16.6 Limin Chemical
16.7 Zhejiang Hisun
16.8 Eastern Along
16.9 Sichuan Qiquan
For more information about this report visit https://www.researchandmarkets.com/r/g948d1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
